EPISODE · Apr 4, 2022 · 27 MIN
Sarah Comstock Discusses the Importance of Easy, Affordable Respiratory Virus Testing
from Mission Matters Business Podcast with Adam Torres · host Adam Torres
Sarah Comstock, Scientific Consultant at GSBiomark and Professor at Corban University, was interviewed by Adam Torres of Mission Matters Business Podcast. Healthcare entrepreneur Sarah Comstock believes Covid-19 testing should be easily accessible and affordable to everyone. Through her work with SalivaDirectTM and GS Biomark, she’s on a mission to make that vision a reality. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be interviewed by Adam on our podcast:https://missionmatters.lpages.co/podcastguest/ Visit our website:https://missionmatters.com/ Support the show More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices
What this episode covers
Sarah Comstock, Scientific Consultant at GSBiomark and Professor at Corban University, was interviewed by Adam Torres of Mission Matters Business Podcast. Healthcare entrepreneur Sarah Comstock believes Covid-19 testing should be easily accessible and affordable to everyone. Through her work with SalivaDirectTM and GS Biomark, she’s on a mission to make that vision a reality. Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be interviewed by Adam on our podcast:https://missionmatters.lpages.co/podcastguest/ Visit our website:https://missionmatters.com/ Support the show More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices
NOW PLAYING
Sarah Comstock Discusses the Importance of Easy, Affordable Respiratory Virus Testing
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m